DE1288448U - - Google Patents

Info

Publication number
DE1288448U
DE1288448U DENDAT1288448D DE1288448DU DE1288448U DE 1288448 U DE1288448 U DE 1288448U DE NDAT1288448 D DENDAT1288448 D DE NDAT1288448D DE 1288448D U DE1288448D U DE 1288448DU DE 1288448 U DE1288448 U DE 1288448U
Authority
DE
Germany
Prior art keywords
dea
der
uen
over
lat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT1288448D
Other languages
German (de)
English (en)
Publication of DE1288448U publication Critical patent/DE1288448U/de
Active legal-status Critical Current

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
DENDAT1288448D Active DE1288448U (enExample)

Publications (1)

Publication Number Publication Date
DE1288448U true DE1288448U (enExample)

Family

ID=608238

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT1288448D Active DE1288448U (enExample)

Country Status (1)

Country Link
DE (1) DE1288448U (enExample)

Similar Documents

Publication Publication Date Title
Marichev et al. Recent advances in the synthesis, structural diversity, and applications of mesoionic 1, 2, 3-triazol-5-ylidene metal complexes
Bock et al. Getting in shape: controlling peptide bioactivity and bioavailability using conformational constraints
Shen et al. Insulin treatment and clinical outcomes in patients with diabetes and heart failure with preserved ejection fraction
Bogale et al. The European CRT Survey: 1 year (9–15 months) follow-up results
Rudinger Characteristics of the amino acids as components of a peptide hormone sequence
Kumar et al. Foldamer scaffolds suggest distinct structures are associated with alternative gains-of-function in a preamyloid toxin
Omaga et al. Structure and biological activity of a turripeptide from Unedogemmula bisaya venom
Conn et al. Pharmacoperone”: What’s in a word
Recum et al. Peptide and protein-based inhibitors of HIV-1 co-receptors
Abernathy et al. The statistical and pharmacological sensitivity of nonclinical QTc analysis comparing jacketed telemetry and multilead snapshot recording in the same dogs
Speirs Eosinopenic activity of epinephrine in adrenalectomized mice
Vuolo et al. Trends in psychotropic-drug-implicated mortality: Psychotropic drugs as a contributing but non-underlying cause of death
Perr Liability of hospital and psychiatrist in suicide
Trompeter et al. Impact of obtaining medications from pharmaceutical company assistance programs on therapeutic goals
Fu et al. Amycretin in obesity: Mechanisms, clinical efficacy, and future perspectives
Chen et al. Synthetic nucleic acids from thymidine and organotin dihalides and their ability to inhibit human cancer cell lines including pancreatic acid and glioblastomas cell lines
Niraghatam Regulatory issues concerning the preclinical testing of synthetic peptides
Parson The art of reading sequence electropherograms
Kolata For scientists racing to cure Alzheimer’s, the math is getting ugly
Silvestre-Roig Prof. Dr. Carlos Silvestre-Roig
DE1530626U (enExample)
Chartrand Bill C53: An Ill-Advised Adventure of State Interference in the Constitutional Evolution of the State-Aboriginal Relationship
Rodriguez et al. HSD58 real-world prescribing of long-acting injectable cabotegravir for treatment of HIV in the United States
Tomasoni et al. August 2023 at a glance: Focus on epidemiology and medical therapy
Zheng et al. HSD56 Utilization of Vascular Assessment Before Lower Extremity Amputation Among Patients With Diabetic Foot Ulcerations in the US